ライフサイエンスコーパス: pericarditis

1 ary study outcome was incessant or recurrent pericarditis.

2 ressed to cardiac tamponade and constrictive pericarditis.

3 s for pericardial effusions and constrictive pericarditis.

4 also to suggest a diagnosis of constrictive pericarditis.

5 and development of severe grossly detectable pericarditis.

6 t observed in clinical cases of constrictive pericarditis.

7 resents a novel animal model of constrictive pericarditis.

8 essential diagnostic feature of constrictive pericarditis.

9 rdiomyopathy and preserved with constrictive pericarditis.

10 common finding in patients with constrictive pericarditis.

11 induced AF episodes in six dogs with sterile pericarditis.

12 ly in symptomatic patients with constrictive pericarditis.

13 ients who had surgically proved constrictive pericarditis.

14 ch is not seen in patients with constrictive pericarditis.

15 trictive compared with those in constrictive pericarditis.

16 a valuable adjunct in assessing constrictive pericarditis.

17 er echocardiographic feature in constrictive pericarditis.

18 ult for a patient with Staphylococcus aureus pericarditis.

19 in relation to the diagnosis of constrictive pericarditis.

20 ist in noninvasively diagnosing constrictive pericarditis.

21 stant and corticosteroid-dependent recurrent pericarditis.

22 stant and corticosteroid-dependent recurrent pericarditis.

23 atients who present with idiopathic or viral pericarditis.

24 with NSAIDs may reduce readmission rates for pericarditis.

25 ine for treatment of multiple recurrences of pericarditis.

26 equiring pericardiocentesis, or constrictive pericarditis.

27 ssociated with the diagnosis of constrictive pericarditis.

28 equiring pericardiocentesis, or constrictive pericarditis.

29 i immunotherapy in patients with tuberculous pericarditis.

30 period, there were 1361 admissions for acute pericarditis.

31 is effective for the treatment of recurrent pericarditis.

32 levation of biomarkers to myocarditis and/or pericarditis.

33 comparison cohort of cancer patients without pericarditis.

34 y reduced the rate of incessant or recurrent pericarditis.

35 uced myocarditis (14.1 to 43.1%, P < 0.001); pericarditis (1.5 to 7.6%, P < 0.001); fibrosis (9.7 to

36 e independently associated with constrictive pericarditis: (1) ventricular septal shift, (2) medial m

37 Among 13 759 patients with acute pericarditis, 1550 subsequently were diagnosed with canc

38 sociated with the development of complicated pericarditis; 2) in select cases, cardiovascular magneti

39 Two days after creation of sterile pericarditis, 24 dogs underwent either a four-part or fi

40 (13), recurrent sternal depression (5), and pericarditis (3).

41 orded more frequently in patients with acute pericarditis (32%) than in those with myopericarditis (1

42 induced AF episodes in six dogs with sterile pericarditis, 372 unipolar electrograms were recorded si

43 disease without an overlap with constrictive pericarditis (39.5+/-18.8 cm/s vs. 4.2+/-3.4 cm/s, p < 0

44 reductions in the incidence of constrictive pericarditis (4.4% vs. 7.8%; hazard ratio, 0.56; 95% CI,

45 nitis (16%), sternal osteomyelitis (6%), and pericarditis (6%).

46 pansion (Ea) in 8 patients with constrictive pericarditis, 7 patients with restriction and 15 normal

47 CVD (dysrhythmia, valvular dysfunction, and pericarditis) (adjusted, 1.29 [1.11-1.50]) in women who

48 tantial number of patients with constrictive pericarditis after pericardiectomy.

49 e Anakinra-Treatment of Recurrent Idiopathic Pericarditis (AIRTRIP) double-blind, placebo-controlled,

50 tic ECG changes, pericarditic chest pain, or pericarditis (all P>0.05).

51 patients with surgically proven constrictive pericarditis, although the histopathological appearance

52 ncrease in the occurrence of myocarditis and pericarditis among those vaccinated.

53 ients with surgically confirmed constrictive pericarditis and 12 patients (control subjects) with hea

54 Sixteen of the 20 patients had tuberculous pericarditis and 4 patients had other diagnoses.

55 raphic data of 50 patients with constrictive pericarditis and 44 with restrictive cardiomyopathy were

56 e and found that rIL-33 induced eosinophilic pericarditis and adversely affected heart function.

57 3 therapeutic approaches on the incidence of pericarditis and atrial fibrillation (AF) after percutan

58 ecimens (70%) from patients with tuberculous pericarditis and by PCR in 14 of 28 specimens (50%) from

59 Constrictive pericarditis and chronic obstructive pulmonary disease h

60 3% +/- 6% and -8% +/- 7% in the constrictive pericarditis and control groups, respectively (p < 0.000

61 ericardiectomy in patients with constrictive pericarditis and correlated postoperative Doppler echoca

62 cine is effective for the treatment of acute pericarditis and first recurrences.

63 of colchicine during a first attack of acute pericarditis and in the prevention of recurrent symptoms

64 Pericardial heart disease comprises only pericarditis and its complications, tamponade and constr

65 are increased in patients with constrictive pericarditis and may be helpful in diagnosing this condi

66 ic similarities between recurrent idiopathic pericarditis and periodic fever syndromes, disorders of

67 ally useful distinction between constrictive pericarditis and restrictive cardiomyopathy and may prov

68 erived from patients with known constrictive pericarditis and restrictive cardiomyopathy.

69 easures: The primary outcomes were recurrent pericarditis and time to recurrence after randomization.

70 cardiogram (ECG), arrhythmias, ischemia, and pericarditis and/or myocarditis-like syndromes, or they

71 ngestive heart failure, 2 were attributed to pericarditis, and 1 was attributed to pulmonary embolism

72 respiratory tract and lead to airsacculitis, pericarditis, and colisepticemia.

73 e development of severe chronic myocarditis, pericarditis, and DCM after CB3 infection by reducing MC

74 ant opportunity to evaluate for constrictive pericarditis, and definite diagnostic criteria are neede

75 of myocardial disease further confirmed that pericarditis, and not myocarditis, was responsible for s

76 ized infection manifesting as perihepatitis, pericarditis, and septicemia.

77 , a minority of patients develop complicated pericarditis, and the care of these patients is the focu

78 Patients hospitalized for acute pericarditis are more commonly male.

79 lae, including left ventricular thrombus and pericarditis, are easily identified.

80 was suspected with atypical ECG changes for pericarditis, arrhythmias, and cardiac troponin elevatio

81 apy for gout and a second-line treatment for pericarditis, as well as a basic part of familial Medite

82 deficient mice developed a fibrous, adhesive pericarditis associated with increased numbers of degran

83 e main diagnostic criterion for constrictive pericarditis by Doppler echocardiography, it can also be

84 esult in camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome, which is characterized pri

85 ing delivery of atrial shocks in the sterile pericarditis canine model of atrial fibrillation.

86 Acute pericarditis caused 0.20% (95% CI, 0.19%-0.22%) of all c

87 The proportion of pericarditis-caused admissions declined by an estimated

88 (<0.36) for dysrhythmia, ambulation status, pericarditis, chronic obstructive pulmonary disease, and

89 In patients with acute pericarditis, colchicine, when added to conventional ant

90 incidence ratios of cancer for patients with pericarditis compared with the general population.

91 One patient had grade 2 pericarditis consistent with radiation recall, and one p

92 ful for differentiating chronic constrictive pericarditis (CP) and restrictive cardiomyopathy (RCM).

93 PV) velocities in patients with constrictive pericarditis (CP) and to describe the influence of atria

94 Differentiation of constrictive pericarditis (CP) from restrictive cardiomyopathy (RCM)

95 ) measurements to differentiate constrictive pericarditis (CP) from restrictive cardiomyopathy (RCMP)

96 The clinical spectrum of constrictive pericarditis (CP) has been affected by a change in incid

97 Constrictive pericarditis (CP) is a disabling disease, and usually re

98 ictive cardiomyopathy (RCM) and constrictive pericarditis (CP) is challenging and, despite combined i

99 n criteria for the diagnosis of constrictive pericarditis (CP) rely on equalization of intracardiac p

100 compare myocardial mechanics of constrictive pericarditis (CP) with restrictive cardiomyopathy (RCM),

101 In constrictive pericarditis (CP), E' is not reduced, despite increased

102 the association of etiology of constrictive pericarditis (CP), pericardial calcification (CA), and o

103 criterion for the diagnosis of constrictive pericarditis (CP).

104 nd natural history of transient constrictive pericarditis (CP).

105 us scleroderma in whom calcific constrictive pericarditis developed.

106 ctive surveillance of MVA recipients for myo/pericarditis did not detect cardiac adverse reactions in

107 all patients with a first-time diagnosis of pericarditis during 1994 to 2013.

108 All patients had chest pain consistent with pericarditis early after the procedure that resolved wit

109 cardiectomy, some patients with constrictive pericarditis fail to improve postoperatively.

110 have included: differentiating constrictive pericarditis from restriction, estimation of left ventri

111 s evaluated for differentiating constrictive pericarditis from restrictive cardiomyopathy.

112 velocity to help differentiate constrictive pericarditis from restrictive cardiomyopathy.

113 n velocities in differentiating constrictive pericarditis from restrictive cardiomyopathy.

114 raphy allows differentiation of constrictive pericarditis from restrictive myocardial disease and sev

115 rom 26.4 +/- 24.2 to 8.8 +/- 22.6 min in the pericarditis group, p = 0.02, and from 33.7 +/- 29.2 to

116 Adult patients with multiple recurrences of pericarditis (>/=two) were randomly assigned (1:1) to pl

117 Most patients with acute pericarditis have a benign course and a good prognosis.

118 topathology for the diagnosis of tuberculous pericarditis in 36 specimens of pericardial fluid and 19

119 tures, including ulcerations in children and pericarditis in adults.

120 Tuberculosis is a major cause of pericarditis in developing countries but accounts for le

121 st common treatment for idiopathic and viral pericarditis in North America and Europe is NSAID therap

122 tructive pulmonary disease from constrictive pericarditis in patients with a respiratory variation of

123 in radiograph strongly suggests constrictive pericarditis in patients with heart failure.

124 educed the rate of subsequent recurrences of pericarditis in patients with multiple recurrences.

125 line treatment for either acute or recurrent pericarditis in the absence of contraindications or spec

126 The primary outcome was recurrent pericarditis in the intention-to-treat population.

127 eviated atrial remodeling, abrogated sterile pericarditis-induced inhomogeneous conduction, and preve

128 Constrictive pericarditis is a potentially reversible cause of heart

129 Tuberculous pericarditis is associated with high morbidity and morta

130 However, calcific constrictive pericarditis is considered rare in the United States sin

131 A physiologic hallmark of constrictive pericarditis is enhanced ventricular interdependence, wh

132 atients who have been hospitalized for acute pericarditis is largely uncharacterized.

133 Pericarditis is the most common form of pericardial dise

134 Pericarditis is the most common form of pericardial dise

135 Constrictive pericarditis is the result of a spectrum of primary card

136 Pericarditis may be a marker of occult cancer and augurs

137 Pericarditis may be a serious complication of malignancy

138 The etiology of pericarditis may be infectious (eg, viral and bacterial)

139 evidence of symptomatic or asymptomatic myo/pericarditis meeting the CDC-case definition and judged

140 f atrial fibrillation were used: the sterile pericarditis model (n = 10) and the rapid atrial pacing

141 A sterile pericarditis model was created using atrial surfaces dus

142 In the canine sterile pericarditis model, the mechanisms of maintenance of AF

143 of the onset of atrial flutter in the canine pericarditis model, we suggest that a transitional rhyth

144 ural effusion (n = 7), pneumothorax (n = 2), pericarditis (n = 2), dislodged sternal bar (n = 3), and

145 eural empyema (n = 4), lung abscess (n = 7), pericarditis (n = 2), osteomyelitis (n = 5), meningitis/

146 eritoneal disease (n = 10), and constrictive pericarditis (n = 2).

147 of the procedure included tamponade (n = 4), pericarditis (n = 3), heart block (n = 1, prior to radio

148 ients with surgically confirmed constrictive pericarditis (n=130) at Mayo Clinic (2008-2010) were com

149 infarction [n = 5], unstable angina [n = 3], pericarditis [n = 2], arrhythmia [n = 12], and heart fai

150 In patients with tuberculous pericarditis, neither prednisolone nor M. indicus pranii

151 hat has been labeled "transient constrictive pericarditis." No large studies have examined the causes

152 Recurrent pericarditis occurred in 9 of 10 patients (90%; incidenc

153 tep with anakinra or placebo until recurrent pericarditis occurred) conducted among 21 consecutive pa

154 ars; range, 18-83 years; 300 men) with acute pericarditis or a myopericardial inflammatory syndrome (

155 CDC-case definition for vaccinia-related myo/pericarditis or who experienced cardiac adverse events f

156 2) in the heart, cardiomyopathy, symptomatic pericarditis, or an arrhythmia requiring treatment; 3) i

157 such as rheumatic heart disease, tuberculous pericarditis, or cardiomyopathy and others having a mark

158 ecimens (50%) from patients with tuberculous pericarditis (P > 0.15).

159 Pericarditis (P = 0.009), pulmonary hypertension (P < 0.

160 Pericarditis patients were more likely to be male (64.9%

161 in-hospital mortality in hospitalized acute pericarditis patients.

162 extraarticular RA manifestations (including pericarditis, pleuritis, and vasculitis) were recorded a

163 Adverse events included severe pericarditis post-operatively (n = 2), late pericardial

164 rs admitted to the hospital because of acute pericarditis (postpericardiotomy and myocardial infarcti

165 We assessed whether pericarditis predicts cancer survival by the Kaplan-Meie

166 the presence of grossly detectable adhesive pericarditis present only in the KO group and characteri

167 l hypertension, hypertrophic cardiomyopathy, pericarditis, pulmonary embolism, hepatic granulomatous

168 d miR-21, were highly upregulated in sterile pericarditis rats.

169 to placebo (n = 10) for 6 months or until a pericarditis recurrence.

170 6 to 65 years of age were at higher risk for pericarditis (relative risk, 2.02; 95% CI, 1.81-2.26; P<

171 ing the evaluation of suspected constrictive pericarditis, repeat Doppler recording of mitral flow ve

172 Constrictive pericarditis represents a serious hemodynamic syndrome t

173 was 80% and 86% among those with and without pericarditis, respectively, and the hazard ratio was 1.5

174 t, type 2 diabetes, heart failure, recurrent pericarditis, rheumatoid arthritis, and smoldering myelo

175 r (2 patients), generator migration (1), and pericarditis secondary to the epicardial patches (1).

176 th cardiac involvement (2 endocarditis and 1 pericarditis), secondary to intravenous bath salts use.

177 ricardial effusion, acute coronary syndrome, pericarditis, significant arrhythmia, and heart failure)

178 disorder camptodactyly-arthropathy-coxa vara-pericarditis syndrome (CACP).

179 disorder camptodactyly-arthropathy-coxa vara-pericarditis syndrome (CACP; MIM 208250) to identify bio

180 disorder camptodactyly-arthropathy-coxa vara-pericarditis syndrome.

181 ipoarabinomannan (LAM) assays in tuberculous pericarditis (TBP).

182 and may identify patients with constrictive pericarditis that will improve with anti-inflammatory th

183 adults with definite or probable tuberculous pericarditis to either prednisolone or placebo for 6 wee

184 In patients with constrictive pericarditis treated with anti-inflammatory therapy, a q

185 rdiovascular complications (one constrictive pericarditis, two right heart failures without underlyin

186 95, a total of 58 patients with constrictive pericarditis underwent pericardiectomy and had at least

187 The in-hospital mortality rate for acute pericarditis was 1.1% (95% CI, 0.6%-1.8%).

188 The <3-month cancer risk among patients with pericarditis was 2.7%, and the standardized incidence ra

189 The proportion of patients who had recurrent pericarditis was 26 (21.6%) of 120 in the colchicine gro

190 incidence rate of hospitalizations for acute pericarditis was 3.32 per 100 000 person-years.

191 The diagnosis of acute pericarditis was based on the presence of 2 of 4 clinica

192 Constrictive pericarditis was confirmed by the surgical report.

193 e tricuspid regurgitation after constrictive pericarditis was considered but ruled out.

194 Vaccinia-associated myo/pericarditis was observed during the US smallpox vaccina

195 ryopreserved specimens from a prior study of pericarditis, we compared PCR to culture and histopathol

196 diotomy and myocardial infarction associated pericarditis were excluded).

197 hritis, discoid lesions, or pleuritis and/or pericarditis were randomized at a ratio of 2:1 to receiv

198 en patients who responded with resolution of pericarditis were randomized to continue anakinra (n = 1

199 uble-blind trial, eligible adults with acute pericarditis were randomly assigned to receive either co

200 ak inspiration in patients with constrictive pericarditis were significantly different from those in

201 Recurrences (mainly as recurrent pericarditis) were the most common complication during f

202 ur knowledge that IL-33 induces eosinophilic pericarditis, whereas soluble ST2 prevents eosinophilia

203 ients with surgically confirmed constrictive pericarditis who had < 25% respiratory variation in mitr

204 ed 41 consecutive patients with constrictive pericarditis who had a cardiovascular magnetic resonance

205 6 locations in 11 patients with constrictive pericarditis who underwent intraoperative transesophagea

206 preliminary study of patients with recurrent pericarditis with colchicine resistance and corticostero

207 Included patients had recurrent pericarditis (with >/=3 previous recurrences), elevation